Director Shareholding

GlaxoSmithKline PLC
8 June 2001

                             Directors' Interests



I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.



7     The Administrators of the SmithKline Beecham US Retirement Savings Plan
June  ('the Plan') notified GlaxoSmithKline plc on the 8 June 2001, that as a
2001  result of movement in the fund on the 7 June 2001, the number of Ordinary
      share ADRs held by the fund had decreased from 17,328,354 to 17,237,058 at
      an average price of $55.4800.


The Plan is a discretionary fund of which all employees or former employees of
SmithKline Beecham plc and its subsidiaries are potential beneficiaries. One
of the Company's directors, Dr J P Garnier is therefore, interested in the
shares held in the fund from time to time in the same way as other employees
or former employees of SmithKline Beecham plc and its subsidiaries.






S M Bicknell

Company Secretary


8 June 2001